Showing results (311-320 of 349) with videos related to

Sort By:
Pageof 35
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 30, 2014
Glucose metabolism in NSCLC is histology-specific and diverges the prognostic potential of 18FDG-PET for adenocarcinoma and squamous cell carcinomaOlga C J Schuurbiers, Tineke W H Meijer, Johannes H A M Kaanders, et al.
European Journal of Orthopaedic Surgery & Traumatology : Orthopedie Traumatologie|September 19, 2019
What is the value of 3D virtual reality in understanding acetabular fractures?Lars Brouwers, Albert F Pull Ter Gunne, Mariska A de Jongh, et al.
Epidemiology and Infection|August 1, 1996
World Health Organisation--supervised interlaboratory comparison of ELISAs for the serological detection of Salmonella enterica serotype Enteritidis in chickensP A Barrow, M Desmidt, R Ducatelle, et al.
Lung Cancer (Amsterdam, Netherlands)|July 28, 2009
Circulating DNA is a non-invasive prognostic factor for survival in non-small cell lung cancerMiep A van der Drift, Bernard E A Hol, Corné H W Klaassen, et al.
Journal of Surgical Oncology|March 28, 2025
Safety and Feasibility of Pulsed Electric Field Ablation for Early-Stage Non-Small Cell Lung Cancer Prior to Surgical ResectionMarcelo Jimenez, Javier Flandes, Erik H F M van der Heijden, et al.
Respiration; International Review of Thoracic Diseases|July 21, 2024
Radiation Principles, Protection, and Reporting for Interventional Pulmonology: A World Association of Bronchology and Interventional Pulmonology White PaperInge N Wijma, Roberto F Casal, George Z Cheng, et al.
Radiology. Artificial Intelligence|June 24, 2026
Benchmarking of AI and Radiologists for Indeterminate Lung Nodule Malignancy Risk Estimation on Screening CT: The LUNA25 ChallengeDré Peeters, Bogdan Obreja, Noa Antonissen, et al.
British Journal of Cancer|July 25, 2019
Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 studyHarry J M Groen, Erik H F M van der Heijden, Theo J Klinkenberg, et al.
Clinical Pharmacology and Therapeutics|September 7, 2022
Off-Label, but on-Evidence? A Review of the Level of Evidence for Pediatric PharmacotherapyTjitske M van der Zanden, Nori J L Smeets, Marika de Hoop-Sommen, et al.
The Journal of Antimicrobial Chemotherapy|January 29, 2026
Do the redefined EUCAST susceptibility categories warrant adjustment of paediatric antibiotic dosages? Pragmatic physiologically based pharmacokinetic modelling of four commonly used agentsMarika A de Hoop-Sommen, Jolien J M Freriksen, Joyce E M van der Heijden, et al.
Pageof 35